人类乳突病毒(HPV)治疗药的全球市场 2023-2027

本报告提供人类乳突病毒(HPV)治疗药的市场规模，预计2022年～2027年之间达9亿5,330万美元，在预测期间内预计以5.15％的年复合成长率成长。

本报告提供人类乳突病毒(HPV)治疗药市场相关资料，整体分析，市场规模与预测，趋势，成长促进因素、课题，再加上网罗约25个供应商的供应商分析等资讯。

提供目前市场情境，最新趋势促进因素，市场环境整体相关最新的分析。由于疫苗的登场，HPV用口服疫苗的开拓，强力的疾病进展，牵引市场。

本调查中，推动今后数年的人类乳突病毒(HPV)治疗药市场成长的主要理由之一，是起立性低血压治疗的新药的研究开发。还有治疗的联合治疗的使用，及采用fludrocortisone的非标籤药物一线药物疗法，导致市场庞大需求。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 各市场分析
• 市场规模 2022
• 市场预测 2022-2027

第4章 市场规模成果

• 人类乳突病毒(HPV)治疗药的全球市场 2017-2021
• 给药途径市场区隔分析 2017-2021
• 适应市场区隔分析 2017-2021
• 各地区分析 2017-2021
• 各国分析 2017-2021

第5章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入业者的威胁
• 替代品的威胁
• 竞争的威胁
• 市场情况

第6章 市场区隔:各给药途径

• 市场区隔
• 比较:各给药途径
• 非口服:市场规模与预测 2022-2027
• 话题的:市场规模与预测 2022-2027
• 市场机会:各给药途径

第7章 各市场区隔指示

• 市场区隔
• 各比较指示
• 子宫颈癌症:市场规模与预测 2022-2027
• 肛门癌症:市场规模与预测 2022-2027
• 外阴癌症及阴道癌症:市场规模与预测 2022-2027
• 其他：市场规模与预测 2022-2027
• 各市场机会指示

第8章 客户形势

• 客户形势概要

第9章 各地区形势

• 各地区市场区隔
• 各地区比较
• 北美:市场规模与预测 2022-2027
• 欧洲:市场规模与预测 2022-2027
• 亚洲:市场规模与预测 2022-2027
• 全球其他地区:市场规模与预测 2022-2027
• 美国:市场规模与预测 2022-2027
• 德国:市场规模与预测 2022-2027
• 加拿大:市场规模与预测 2022-2027
• 中国:市场规模与预测 2022-2027
• 巴西:市场规模与预测 2022-2027
• 市场机会:各地区

第10章 促进因素，课题，及趋势

• 推动市场要素
• 市场课题
• 推动因素与课题的影响
• 市场趋势

第11章 业者情势

• 概要
• 业者情势
• 混乱状况
• 产业的风险

第12章 供应商分析

• 交易厂商
• 供应商的市场定位
• 2A Pharma ApS
• AbbVie Inc.
• Bausch Health Co. Inc.
• Bavarian Nordic AS
• BioVaxys Technology Corp.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• ISA Pharmaceuticals BV
• Merck and Co. Inc.
• Serum Institute of India Pvt. Ltd.
• Walvax Biotechnology Co. Ltd.
• Xiamen Innovax Biotech Co. Ltd.

第13章 附录

Technavio has been monitoring the human papillomavirus (HPV) therapeutics market and is forecast to grow by $953.3 mn during 2022-2027, accelerating at a CAGR of 5.15% during the forecast period. Our report on the human papillomavirus (HPV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advent of vaccines, development of oral vaccines for HPV, and strong disease progression.

Technavio's human papillomavirus (HPV) therapeutics market is segmented as below:

By Route of Administration

• Parenteral
• Topical

By Indication

• Cervical cancer
• Anal cancer
• Vulvar and vaginal cancer
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the r and d of new drugs for orthostatic hypotension treatment as one of the prime reasons driving the human papillomavirus (HPV) therapeutics market growth during the next few years. Also, use of combination therapy in treatment and the adoption of fludrocortisone as off label first line pharmacotherapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the human papillomavirus (HPV) therapeutics market covers the following areas:

• Human papillomavirus (HPV) therapeutics market sizing
• Human papillomavirus (HPV) therapeutics market forecast
• Human papillomavirus (HPV) therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human papillomavirus (HPV) therapeutics market vendors that include 2A Pharma ApS, AbbVie Inc., Bavarian Nordic AS, BioVaxys Technology Corp., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ISA Pharmaceuticals BV, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Xiamen Innovax Biotech Co. Ltd., Merck and Co. Inc., Bausch Health Co. Inc., and Inovio Pharmaceuticals Inc. Also, the human papillomavirus (HPV) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021 ($ million)
• 4.2 route of administration Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - route of administration Segment 2017 - 2021 ($ million)
• 4.3 Indication Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration

• 6.1 Market segments
• Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
• 6.2 Comparison by Route of Administration
• Exhibit 32: Chart on Comparison by Route of Administration
• Exhibit 33: Data Table on Comparison by Route of Administration
• 6.3 Parenteral - Market size and forecast 2022-2027
• Exhibit 34: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
• 6.4 Topical - Market size and forecast 2022-2027
• Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Route of Administration
• Exhibit 42: Market opportunity by Route of Administration ($ million)
• Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Indication

• 7.1 Market segments
• Exhibit 44: Chart on Indication - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Indication - Market share 2022-2027 (%)
• 7.2 Comparison by Indication
• Exhibit 46: Chart on Comparison by Indication
• Exhibit 47: Data Table on Comparison by Indication
• 7.3 Cervical cancer - Market size and forecast 2022-2027
• Exhibit 48: Chart on Cervical cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Cervical cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Cervical cancer - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Cervical cancer - Year-over-year growth 2022-2027 (%)
• 7.4 Anal cancer - Market size and forecast 2022-2027
• Exhibit 52: Chart on Anal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Anal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Anal cancer - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Anal cancer - Year-over-year growth 2022-2027 (%)
• 7.5 Vulvar and vaginal cancer - Market size and forecast 2022-2027
• Exhibit 56: Chart on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
• 7.6 Others - Market size and forecast 2022-2027
• Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Indication
• Exhibit 64: Market opportunity by Indication ($ million)
• Exhibit 65: Data Table on Market opportunity by Indication ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 Canada - Market size and forecast 2022-2027
• Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Brazil - Market size and forecast 2022-2027
• Exhibit 103: Chart on Brazil - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Brazil - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Brazil - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 2A Pharma ApS
• Exhibit 115: 2A Pharma ApS - Overview
• Exhibit 116: 2A Pharma ApS - Product / Service
• Exhibit 117: 2A Pharma ApS - Key offerings
• 12.4 AbbVie Inc.
• Exhibit 118: AbbVie Inc. - Overview
• Exhibit 119: AbbVie Inc. - Product / Service
• Exhibit 120: AbbVie Inc. - Key news
• Exhibit 121: AbbVie Inc. - Key offerings
• 12.5 Bausch Health Co. Inc.
• Exhibit 122: Bausch Health Co. Inc. - Overview
• Exhibit 123: Bausch Health Co. Inc. - Business segments
• Exhibit 124: Bausch Health Co. Inc. - Key news
• Exhibit 125: Bausch Health Co. Inc. - Key offerings
• Exhibit 126: Bausch Health Co. Inc. - Segment focus
• 12.6 Bavarian Nordic AS
• Exhibit 127: Bavarian Nordic AS - Overview
• Exhibit 128: Bavarian Nordic AS - Product / Service
• Exhibit 129: Bavarian Nordic AS - Key offerings
• 12.7 BioVaxys Technology Corp.
• Exhibit 130: BioVaxys Technology Corp. - Overview
• Exhibit 131: BioVaxys Technology Corp. - Product / Service
• Exhibit 132: BioVaxys Technology Corp. - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 GlaxoSmithKline Plc
• Exhibit 138: GlaxoSmithKline Plc - Overview
• Exhibit 139: GlaxoSmithKline Plc - Business segments
• Exhibit 140: GlaxoSmithKline Plc - Key offerings
• Exhibit 141: GlaxoSmithKline Plc - Segment focus
• 12.10 Inovio Pharmaceuticals Inc.
• Exhibit 142: Inovio Pharmaceuticals Inc. - Overview
• Exhibit 143: Inovio Pharmaceuticals Inc. - Product / Service
• Exhibit 144: Inovio Pharmaceuticals Inc. - Key news
• Exhibit 145: Inovio Pharmaceuticals Inc. - Key offerings
• 12.11 ISA Pharmaceuticals BV
• Exhibit 146: ISA Pharmaceuticals BV - Overview
• Exhibit 147: ISA Pharmaceuticals BV - Product / Service
• Exhibit 148: ISA Pharmaceuticals BV - Key offerings
• 12.12 Merck and Co. Inc.
• Exhibit 149: Merck and Co. Inc. - Overview
• Exhibit 150: Merck and Co. Inc. - Business segments
• Exhibit 151: Merck and Co. Inc. - Key news
• Exhibit 152: Merck and Co. Inc. - Key offerings
• Exhibit 153: Merck and Co. Inc. - Segment focus
• 12.13 Serum Institute of India Pvt. Ltd.
• Exhibit 154: Serum Institute of India Pvt. Ltd. - Overview
• Exhibit 155: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibit 156: Serum Institute of India Pvt. Ltd. - Key offerings
• 12.14 Walvax Biotechnology Co. Ltd.
• Exhibit 157: Walvax Biotechnology Co. Ltd. - Overview
• Exhibit 158: Walvax Biotechnology Co. Ltd. - Product / Service
• Exhibit 159: Walvax Biotechnology Co. Ltd. - Key offerings
• 12.15 Xiamen Innovax Biotech Co. Ltd.
• Exhibit 160: Xiamen Innovax Biotech Co. Ltd. - Overview
• Exhibit 161: Xiamen Innovax Biotech Co. Ltd. - Product / Service
• Exhibit 162: Xiamen Innovax Biotech Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 163: Inclusions checklist
• Exhibit 164: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 165: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 166: Research methodology
• Exhibit 167: Validation techniques employed for market sizing
• Exhibit 168: Information sources
• 13.5 List of abbreviations
• Exhibit 169: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - route of administration Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Route of Administration
• Exhibits33: Data Table on Comparison by Route of Administration
• Exhibits34: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Topical - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Route of Administration ($ million)
• Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits44: Chart on Indication - Market share 2022-2027 (%)
• Exhibits45: Data Table on Indication - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Indication
• Exhibits47: Data Table on Comparison by Indication
• Exhibits48: Chart on Cervical cancer - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Cervical cancer - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Cervical cancer - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Cervical cancer - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Anal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Anal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Anal cancer - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Anal cancer - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits64: Market opportunity by Indication ($ million)
• Exhibits65: Data Table on Market opportunity by Indication ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share by geography 2022-2027 (%)
• Exhibits68: Data Table on Market share by geography 2022-2027 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on Brazil - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on Brazil - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on Brazil - Year-over-year growth 2022-2027 (%)
• Exhibits107: Market opportunity by geography ($ million)
• Exhibits108: Data Tables on Market opportunity by geography ($ million)
• Exhibits109: Impact of drivers and challenges in 2022 and 2027
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: 2A Pharma ApS - Overview
• Exhibits116: 2A Pharma ApS - Product / Service
• Exhibits117: 2A Pharma ApS - Key offerings
• Exhibits118: AbbVie Inc. - Overview
• Exhibits119: AbbVie Inc. - Product / Service
• Exhibits120: AbbVie Inc. - Key news
• Exhibits121: AbbVie Inc. - Key offerings
• Exhibits122: Bausch Health Co. Inc. - Overview
• Exhibits123: Bausch Health Co. Inc. - Business segments
• Exhibits124: Bausch Health Co. Inc. - Key news
• Exhibits125: Bausch Health Co. Inc. - Key offerings
• Exhibits126: Bausch Health Co. Inc. - Segment focus
• Exhibits127: Bavarian Nordic AS - Overview
• Exhibits128: Bavarian Nordic AS - Product / Service
• Exhibits129: Bavarian Nordic AS - Key offerings
• Exhibits130: BioVaxys Technology Corp. - Overview
• Exhibits131: BioVaxys Technology Corp. - Product / Service
• Exhibits132: BioVaxys Technology Corp. - Key offerings
• Exhibits133: F. Hoffmann La Roche Ltd. - Overview
• Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits135: F. Hoffmann La Roche Ltd. - Key news
• Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits138: GlaxoSmithKline Plc - Overview
• Exhibits139: GlaxoSmithKline Plc - Business segments
• Exhibits140: GlaxoSmithKline Plc - Key offerings
• Exhibits141: GlaxoSmithKline Plc - Segment focus
• Exhibits142: Inovio Pharmaceuticals Inc. - Overview
• Exhibits143: Inovio Pharmaceuticals Inc. - Product / Service
• Exhibits144: Inovio Pharmaceuticals Inc. - Key news
• Exhibits145: Inovio Pharmaceuticals Inc. - Key offerings
• Exhibits146: ISA Pharmaceuticals BV - Overview
• Exhibits147: ISA Pharmaceuticals BV - Product / Service
• Exhibits148: ISA Pharmaceuticals BV - Key offerings
• Exhibits149: Merck and Co. Inc. - Overview
• Exhibits150: Merck and Co. Inc. - Business segments
• Exhibits151: Merck and Co. Inc. - Key news
• Exhibits152: Merck and Co. Inc. - Key offerings
• Exhibits153: Merck and Co. Inc. - Segment focus
• Exhibits154: Serum Institute of India Pvt. Ltd. - Overview
• Exhibits155: Serum Institute of India Pvt. Ltd. - Product / Service
• Exhibits156: Serum Institute of India Pvt. Ltd. - Key offerings
• Exhibits157: Walvax Biotechnology Co. Ltd. - Overview
• Exhibits158: Walvax Biotechnology Co. Ltd. - Product / Service
• Exhibits159: Walvax Biotechnology Co. Ltd. - Key offerings
• Exhibits160: Xiamen Innovax Biotech Co. Ltd. - Overview
• Exhibits161: Xiamen Innovax Biotech Co. Ltd. - Product / Service
• Exhibits162: Xiamen Innovax Biotech Co. Ltd. - Key offerings
• Exhibits163: Inclusions checklist
• Exhibits164: Exclusions checklist
• Exhibits165: Currency conversion rates for US$
• Exhibits166: Research methodology
• Exhibits167: Validation techniques employed for market sizing
• Exhibits168: Information sources
• Exhibits169: List of abbreviations